Medicare Enrolled
Dr. Dina Ibrahim, M.D
Hematology & Oncology · Fresno, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ibrahim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ibrahim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ibrahim
Dr. Dina Ibrahim is a hematology & oncology specialist in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ibrahim performed 1,608 Medicare services across 883 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ibrahim received a total of $11,624 from 60 pharmaceutical and/or device companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ibrahim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 43% volume in CA
$11,624 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,608
Medicare services
Top 43% in CA for hematology & oncology
883
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~85 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
862 | $89 | $320 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
127 | $140 | $449 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
121 | $42 | $111 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
102 | $1 | $5 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
101 | $11 | $45 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $63 | $229 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
79 | $60 | $190 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
65 | $92 | $266 |
| New patient office visit, complex (60-74 min) | 33 | $166 | $580 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $123 | $434 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $138 | $489 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,624
Total received (2018-2024)
Avg $1,661/year across 7 years
Top 30% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
355
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,030 (60.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,099 (35.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$495 (4.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,456
2023
$806
2022
$551
2021
$340
2020
$226
2019
$1,571
2018
$4,673
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$403
PFIZER INC.
$231
GlaxoSmithKline, LLC.
$197
Merck Sharp & Dohme LLC
$192
Eisai Inc.
$178
Takeda Pharmaceuticals U.S.A., Inc.
$175
Boehringer Ingelheim Pharmaceuticals, Inc.
$173
AstraZeneca Pharmaceuticals LP
$166
E.R. Squibb & Sons, L.L.C.
$147
Astellas Pharma US Inc
$136
GENZYME CORPORATION
$133
Exelixis Inc.
$121
Janssen Biotech, Inc.
$107
Genentech USA, Inc.
$101
ABBVIE INC.
$101
Daiichi Sankyo Inc.
$99
Celgene Corporation
$70
Regeneron Healthcare Solutions, Inc.
$69
BeiGene USA, Inc.
$66
PUMA BIOTECHNOLOGY, INC.
$50
Aveo Pharmaceuticals, Inc.
$47
PharmaEssentia USA Corporation
$47
Mirati Therapeutics, Inc.
$38
Myriad Genetic Laboratories, Inc.
$37
Medtronic, Inc.
$35
SpringWorks Therapeutics, Inc.
$33
Pharmacosmos Therapeutics Inc.
$32
Deciphera Pharmaceuticals Inc.
$26
Rigel Pharmaceuticals, Inc.
$26
Tempus AI, Inc
$25
Incyte Corporation
$24
SERVIER PHARMACEUTICALS LLC
$23
BioMarin Pharmaceutical Inc.
$23
SOBI, INC
$21
Ipsen Biopharmaceuticals, Inc
$20
Stemline Therapeutics Inc.
$20
Lilly USA, LLC
$19
Amneal Pharmaceuticals LLC
$17
Tactile Systems Technology Inc
$16
ARRAY BIOPHARMA INC
$15
Top 3 companies account for 24.0% of 2024 payments
All-time payments by company (2018-2024) ›
Puma Biotechnology, Inc.
$4,099
Novartis Pharmaceuticals Corporation
$654
PFIZER INC.
$624
Lilly USA, LLC
$582
E.R. Squibb & Sons, L.L.C.
$572
Jazz Pharmaceuticals Inc.
$457
GENZYME CORPORATION
$316
AstraZeneca Pharmaceuticals LP
$265
Astellas Pharma US Inc
$260
GlaxoSmithKline, LLC.
$258
Janssen Biotech, Inc.
$252
Exelixis Inc.
$238
Takeda Pharmaceuticals U.S.A., Inc.
$221
Merck Sharp & Dohme LLC
$216
Boehringer Ingelheim Pharmaceuticals, Inc.
$193
Daiichi Sankyo Inc.
$180
Eisai Inc.
$178
Medtronic Vascular, Inc.
$159
Genentech USA, Inc.
$150
Celgene Corporation
$139
ABBVIE INC.
$101
Regeneron Healthcare Solutions, Inc.
$91
Amgen Inc.
$85
TerSera Therapeutics LLC
$78
AVEO Pharmaceuticals, Inc.
$76
PharmaEssentia USA Corporation
$68
BeiGene USA, Inc.
$66
Seagen Inc.
$65
Octapharma USA, Inc.
$63
Gilead Sciences, Inc.
$57
PUMA BIOTECHNOLOGY, INC.
$50
SOBI, INC
$49
Karyopharm Therapeutics Inc.
$48
Aveo Pharmaceuticals, Inc.
$47
Ipsen Biopharmaceuticals, Inc
$41
Mirati Therapeutics, Inc.
$38
Myriad Genetic Laboratories, Inc.
$37
Incyte Corporation
$37
AbbVie, Inc.
$36
Kite Pharma, Inc.
$36
Medtronic, Inc.
$35
SpringWorks Therapeutics, Inc.
$33
Pharmacosmos Therapeutics Inc.
$32
Deciphera Pharmaceuticals Inc.
$26
Rigel Pharmaceuticals, Inc.
$26
Tempus AI, Inc
$25
Bayer HealthCare Pharmaceuticals Inc.
$23
SERVIER PHARMACEUTICALS LLC
$23
BioMarin Pharmaceutical Inc.
$23
Sun Pharmaceutical Industries Inc.
$22
Dova Pharmaceuticals
$21
Merck Sharp & Dohme Corporation
$20
Stemline Therapeutics Inc.
$20
PORTOLA PHARMACEUTICALS, LLC
$18
Amneal Pharmaceuticals LLC
$17
ImmunoGen, Inc.
$17
Tactile Systems Technology Inc
$16
TESARO, Inc.
$16
ARRAY BIOPHARMA INC
$15
Pharmacyclics LLC, An AbbVie Company
$12
Top 3 companies account for 46.3% of all-time payments
Associated products mentioned in payments ›
ALPROLIX · ALUNBRIG · ANDEXXA · AVASTIN · Abraxane · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CREON · Cabometyx · CardioInsight · Columvi · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ERLEADA · Elahere · Enhertu · Erleada · FOTIVDA · FRUZAQLA · Fabhalta · Flexitouch Plus · GILOTRIF · HawkOne · IBRANCE · ICLUSIG · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lupron Depot · MEKINIST · MONOFERRIC · MYRISK · NINLARO · Nerlynx · Nplate · ODOMZO · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION SYSTEM · Onivyde · Orserdu · PIQRAY · PLUVICTO · PROMACTA · Phesgo · Pomalyst · QINLOCK · REBLOZYL · ROCTAVIAN · RYBREVANT · Rezlidhia · SANDOSTATIN · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUTENT · TAGRISSO · TALVEY · TASIGNA · TUKYSA · Tecentriq · Tibsovo · VARUBI · VERZENIO · VIBERZI · VONJO · VOTRIENT · Venclexta · Vitrakvi · Vyloy · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XPOVIO · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
28
Per 100K population
2.8
County median income
$71,434
Nearest hospital
FRESNO SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ibrahim is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ibrahim experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ibrahim performed 862 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ibrahim receive payments from pharmaceutical companies?
Yes. Dr. Ibrahim received a total of $11,624 from 60 companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ibrahim's costs compare to other hematology & oncology specialists in Fresno?
Dr. Ibrahim's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ibrahim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fresno
Browse hematology & oncology specialists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Puma Biotechnology, Inc. Payments to Doctors
See all physicians who received payments from Puma Biotechnology, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology